AzTrials
AzTrials

Metabolic Syndrome XPROMETSNCT02949622

Multimodal Intervention Program for Patients With Metabolic Syndrome

A study testing Multimodal intervention program and Lifestyle counseling in people with Metabolic Syndrome X, run by Universidad de Granada at 1 site in Spain.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study is to identify the psychological, emotional and lifestyle variables that can have an influence on the different components of metabolic syndrome (MetS) and develop a program for change lifestyle in this patients. Read more about this study

Who is it for?
Ages 25 to 65 years
Conditions the study is for
Metabolic Syndrome X
What is being tested?
Multimodal intervention program and Lifestyle counseling
Could I receive a placebo?
No, everyone receives an active treatment
How many people
136 participants
Where
1 siteSpain
Study dates
Feb 2013to Oct 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 25 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Between 25 and 65 years age
  • Waist circumference >88 cm for women and >102 cm for men
  • Blood pressure: systolic ≥ 130 mmHg and diastolic ≥ 85 mmHg
  • Fasting glucose level ≥ 110mg/dL
  • Triglycerides: ≥ 150 mg/dL
  • HDL cholesterol ≤40 mg/dL in men and ≤50 mg/DL in women

Who cannot join

  • Osteoarthritis,
  • Active inflammatory diseases,
  • Severe psychiatric disorders and/or significant cognitive impairment assessed using the Mini-Mental State Examination.

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • Jaqueline Garcia da Silva

    Granada, 18009

Other trials in Spain

About this study

Official title: Development and Validation of a Multimodal Intervention Program for Patients With Metabolic Syndrome

The aim of this study is to identify the psychological, emotional and lifestyle variables that can have an influence on the different components of metabolic syndrome (MetS) and develop a program for change lifestyle in this patients.

Being tested
Multimodal intervention program, Lifestyle counseling
Keywords
Metabolic syndrome, Mediterranean diet, Stress, quality of life, psychological factors
Medical subject headings
Metabolic Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Multimodal intervention programBehavioural

    The intervention is structured as follows:

    Review of previous session (20 min) Agenda and goals (5 min) Presentation of the topic to be worked (15 min) Training (60 min) Summary and feedback (15 min)

  • Lifestyle counselingOther

    The group of lifestyle counseling will have basic guidelines, according to the recommendations of public health.

Study groups in NCT02949622
Study groupRoleWhat they receive
Multimodal intervention programExperimentalThe intervention program will be in group format, with a size of 10 to 12 patients per group and with an extension of 12 sessions. The treatment program will feature sessions with psychoeducation of metabolic syndrome and treatment model, problem solving, stress management, anger management, social skills, self-efficacy and social support.
Receives: Behavioral: Multimodal intervention program
Lifestyle counselingActive comparatorThe group of lifestyle counseling will have basic guidelines, according to the recommendations of public health.
Receives: Other: Lifestyle counseling

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Weight

    weight (Kg)

    Measured: 2 minutes

  2. Waist circumference

    (cm). Measured using a tape measure placed in a horizontal plane, located at the midpoint between the last rib and the iliac crest

    Measured: 2 minutes

  3. Blood pressure

    Taken according to the recommendations of the American Heart Association, and considering the mean of three readings, each separated by two minutes.

    Measured: 15 minutes

  4. Lipid profile

    lipid profile (HDL-C, total cholesterol, triglycerides)

    Measured: 3 minutes

  5. Glycemic profile (fasting glucose)

    glycemic profile (fasting glucose)

    Measured: 3 minutes

Secondary outcomes (6)
  1. State-Trait Anger Expression Inventory-2 - STAXI-2

    To determine diverse components of anger, such as experience, expression and control, as well as its facets such as state and trait, the Inventory of Expression of Anger State-Trait (STAXI-2) was used. It consists of 49 items organised in 6 scales and 5 subscales, permitting the attainment of an index for each scale and subscale, as well as a general index of the inventory.

    Measured: 5 minutes

  2. Perceived Stress Scale -PSS

    To measure the perceived stress during the previous month, the Perceived Stress Scale was used, with a total of 14 items.

    Measured: 5 minutes

  3. Assertiveness Inventory

    To evaluate the general assertiveness, the Assertiveness Inventory (AI) consisting of 30 items was used .

    Measured: 5 minutes

  4. Medical Outcomes Study 12-Item Short Form - SF-12

    To determine the health-related quality of life the Medical Outcomes Study 12-Item Short Form (SF-12), which is composed of two components related to physical and mental health, was used.

    Measured: 5 minutes

  5. Mediterranean-diet scale

    To evaluate the level of adherence to the Mediterranean diet (MedDiet). Consisting of 14 items that evaluate whether foods are included that can prevent cardiovascular risk such as olive oil, fish, vegetables, fruits, cereals and also foods that can increase the chances of risk such as cold meats, trans fats and excess salt. The degree of adherence to the MedDiet is given by the sum of the items. A score below 11 is considered low adherence and higher than 11 as high.

    Measured: 5 minutes

  6. Fagerström Test for Nicotine Dependence

    To evaluate the degree of physical dependence on nicotine. The test consists of six items with two or four response alternatives. The score ranges from 0 to 10. High scores in the FTND (6 or more) indicate a high degree of dependence.

    Measured: 5 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Oct 2016 (estimated)
  2. Study startFeb 2013
  3. Primary completionSep 2016
  4. Study completionOct 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
136 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02949622
Sponsor's protocol ID
CAPES 5566-10-0
Acronym
PROMETS
Status last verified
Jun 2017
First submitted
14 Oct 2016
Last updated
21 Jun 2017
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Publications

  • Garcia-Silva J, Borrego IRS, Navarrete NN, Peralta-Ramirez MI, Aguila FJ, Caballo VE. Efficacy of cognitive-behavioural therapy for lifestyle modification in metabolic syndrome: a randomised controlled trial with a 18-months follow-up. Psychol Health. 2024 Jan-Feb;39(2):195-215. doi: 10.1080/08870446.2022.2055023. Epub 2022 Mar 28.

    PubMed 35345950

Questions about this trial

What is this clinical trial studying?

A study testing Multimodal intervention program and Lifestyle counseling in people with Metabolic Syndrome X, run by Universidad de Granada at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Jun 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Weight (time frame: 2 minutes). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02949622, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Jun 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in